Results 171 to 180 of about 14,195,110 (309)

Virtual sensing at low computational cost for active noise control

, 2015
In active noise control, global noise attenuation is not achievable when the size of the controlled environment is significantly larger than the wave length of the noise, and satisfactory performance is obtained only in the immediate vicinity of the ...
PIRODDI, LUIGI, Patiño, D., Quintana, R.   +2 more
core  

Paying in the dark: third-party administrator fees and the limits of employer cost control in self-insured health plans. [PDF]

Health Aff Sch
Buttorff C, Rasmussen PW, Bhandarkar M, Shiferaw M, Duffy EL.   +4 more
europepmc   +1 more source

Subjective Cognitive Concerns and Cognitive Trajectories in Parkinson's Disease: Biomarker Impact

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To examine the relationship of subjective cognitive concerns (SCC) with biomarkers of Alzheimer's disease (AD), neurodegeneration, and Parkinson's disease (PD) and domain‐specific cognitive trajectories among cognitively unimpaired persons with de novo PD. Method Cognitively unimpaired participants with SCC (n = 294) and without SCC (
Francesca V. Lopez, Fareshte Erani, Katherine J. Bangen, David G. Coughlin, Douglas Galasko, Kelsey R. Thomas   +5 more
wiley   +1 more source

Robust Learning-Based Detection with Cost Control and Byzantine Mitigation. [PDF]

Sensors (Basel)
Zhong C, Gursoy MC, Velipasalar S.
europepmc   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley   +1 more source

Study on inpatient expenses and cost control strategies for breast cancer patients based on Diagnosis-Intervention Packet. [PDF]

Front Public Health
Yue L, Pan Z, Chen W.
europepmc   +1 more source

Artificial Intelligence in Systemic Sclerosis: Clinical Applications, Challenges, and Future Directions

Arthritis Care &Research, EarlyView.
Systemic sclerosis (SSc) is a rare autoimmune disease defined by immune dysregulation, vasculopathy, and progressive fibrosis of the skin and internal organs. Despite advances in care, major complications such as interstitial lung disease (ILD) and myocardial involvement remain the leading causes of morbidity and mortality.
Cristiana Sieiro Santos, José Miguel Sequí‐Sabater, Diego Benavent   +2 more
wiley   +1 more source

Evaluation of the Use of a Novel Intelligent Diagnosis and Cost Control System on Pediatric Bronchopneumonia Outcomes: Retrospective Cohort Study. [PDF]

JMIR Pediatr Parent
Wu Y, Liu K, Mao X, Wu D, Zhu F.
europepmc   +1 more source

Immunosuppressive Drug Use in Limited Systemic Sclerosis: An International Survey

Arthritis Care &Research, EarlyView.
Objective Current guidelines recommend immunosuppressive treatment for diffuse cutaneous systemic sclerosis but are less clear on their use in limited cutaneous systemic sclerosis (lcSSc) in the absence of internal organ complications. We conducted an international survey to understand current immunosuppressive drug prescribing patterns in lcSSc ...
Sabrina Hoa, Yicheng Mu, Marie Hudson, Janet Pope   +3 more
wiley   +1 more source

Deep learning for cardiovascular management: optimizing pathways and cost control under diagnosis-related group models. [PDF]

Front Artif Intell
Chen H, Zeng Y, Cai.
europepmc   +1 more source